Biogel

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biogel

What is Biogel? A Concise Overview

Property Description
Active ingredient Ketoconazole (a synthetic compound)
Form Topical Gel (aqueous/hydro-alcoholic base)
Pharmacological Class Antifungal Agent / Imidazole Antifungal
General Purpose To combat superficial fungal infections
Origin Synthetic

What Type of Medicine is Biogel with Ketoconazole?

Biogel is a specific topical pharmaceutical preparation classified as a synthetic broad-spectrum antifungal agent. It belongs to the broader pharmacological class of azole antifungals, which are chemical compounds designed to combat fungal pathogens. Supported by pharmacological studies, this class of agents is clinically recognized for its reliable efficacy against a wide range of dermatophytes and yeasts. The drug’s origin is entirely synthetic, meaning the active ingredient is a chemically manufactured small molecule, Ketoconazole. This compound's chemical structure places it within the imidazole antifungal subgroup, a well-established category of medicines used for the localized management of superficial fungal infections.


Composition and Form: The Ketoconazole Topical Gel

The core of Biogel is the potent single-ingredient product, Ketoconazole, presented in a specific Topical Gel dosage form. As a topical preparation, the gel is designed for direct application to the skin or scalp, distinguishing it from systemic formulations like oral tablets, which are reserved for deeper, more serious conditions. The Topical Gel uses an aqueous or hydro-alcoholic base/vehicle matrix to deliver the active ingredient efficiently, ensuring effective local concentration at the site of the ailment. This specific drug form represents a differentiating factor, as it offers a non-greasy consistency favored by patients for application on hair-bearing areas or large surface areas.


What is the General Purpose of This Antifungal Agent?

The general purpose of the antifungal agent in Biogel is to resolve the symptoms and proliferation associated with superficial fungal infections, such as those that cause flaking and irritation. The physiological action of the Ketoconazole compound is that of a fungistatic agent, which means it works by stopping the growth of the fungal organisms. It achieves this by disrupting the ergosterol synthesis necessary for the construction of the fungal cell membrane. By structurally debilitating the cell wall and halting proliferation, the topical preparation helps the patient control and overcome the symptoms related to the presence of the infecting organism on the skin or scalp.

Regulatory References

  1. Ketoconazole - LiverTox - NCBI Bookshelf

What side effects are possible with Biogel?

Possible Side Effects and Safety Information

The safety profile for Biogel (topical ketoconazole gel) is characterized primarily by localized reactions at the application site, reflecting its function as a skin-applied antifungal agent. The regulatory documents classify adverse reactions based on frequency and affected system.


Adverse Reactions and Frequencies

Adverse reactions are formally grouped according to standard regulatory classification (System-Organ Classes):

Classification Common Side Effects (1/100 to <1/10)
Administration Site Burning sensation, Pruritus (itching), Erythema (redness)
Skin Skin burning sensation

Less common reactions (Uncommon: 1/1,000 to <1/100) include application site irritation, pain, dryness, and dermatitis. Events classified under Nervous System Disorders, such as headache and dizziness, have also been officially documented.


Systemic Safety and Constraints

Serious Adverse Reactions and systemic toxicity (such as hepatitis or hormonal changes) associated with oral ketoconazole are not observed with the topical gel, as regulatory data indicates minimal to non-detectable systemic absorption. The official safety constraints include a classification that the gel formulation is flammable, requiring avoidance of heat and open flame during and immediately after application.


Population-Specific Safety

Contraindication exists for individuals with known hypersensitivity to the active ingredient or its excipients. Safety and effectiveness of the gel have not been established in pediatric patients younger than 12 years of age. For pregnancy and lactation, regulatory statements indicate that systemic plasma concentrations are generally non-detectable following topical use.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents for Biogel (Ketoconazole Topical Gel) define the overdose profile primarily by its topical nature and the potential for accidental ingestion.


Documented Overdose Manifestations

In cases of excessive topical application, the documented signs are localized dermal reactions. These may include erythema (redness), oedema (swelling), and a burning sensation. These localized manifestations are classified as self-limiting and are expected to disappear upon discontinuation of the treatment. Official labeling for the gel formulation also notes that no experience of overdose has been reported.


When to Seek Urgent Medical Help

Urgent medical help is explicitly required in the event of accidental ingestion of the product. The regulatory guidance states that a health care provider or poison control center should be contacted immediately.

The risk of severe systemic complications is low; the toxic effects associated with oral ketoconazole, such as hepatic or endocrine effects, have not been seen with topically administered ketoconazole. Therefore, the focus remains on the specific instruction for ingestion.


Management and Treatment

Following accidental ingestion, the officially described intervention is the administration of supportive and symptomatic measures. Regulatory information does not list any specific antidote for ketoconazole.

Therapeutic Uses of Biogel

What Biogel Treats: Main Uses and Benefits

Biogel is an antifungal medication relevant for the topical management of certain conditions where fungal or yeast proliferation causes noticeable symptomatic discomfort. Its use is common in clinical contexts to address conditions such as Seborrheic Dermatitis (including associated symptoms of dandruff), and superficial fungal infections like Tinea Corporis (ringworm), Tinea Cruris (jock itch), and Tinea Pedis (athlete's foot).

The therapeutic benefit helps ease the pruritus (itching) and localized redness (erythema) that accompany active infections. The medication provides symptomatic support and assists with managing the characteristic flaking and scaling that interferes with daily functioning. By addressing the symptomatic discomfort, the treatment may contribute to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Persistent Flaking The medication is commonly used when scaling and irritation are persistent or recurrent, focusing on conditions presenting with inflammatory or irritative processes on the skin or scalp.

Eligibility and Restrictions for Use

Who can and cannot use Biogel?


The eligibility for Biogel (Ketoconazole Topical Gel) is strictly defined by regulatory documentation concerning patient populations.

Contraindications and Exclusions

The primary non-eligibility rule is an absolute contraindication for individuals with a known history of hypersensitivity (allergic reaction) to the active substance, ketoconazole, or any other inactive ingredient in the gel formulation. Use of this medication is indicated only for immunocompetent adults and children; its safety and efficacy are not established in immunocompromised patients.

Age-Related Eligibility

The product is approved for use in adults and adolescents 12 years of age and older. Safety and effectiveness have not been established in the pediatric population under 12 years of age. For older adult subjects, no overall differences in safety or effectiveness were observed, though regulator documents note that greater sensitivity of some older individuals cannot be ruled out.

Maternal Status and Conditional Use

Use during pregnancy is categorized as Pregnancy Category C. It is strictly conditioned upon the assessment that the potential benefit justifies the potential risk to the fetus. Likewise, caution must be exercised when administered to a nursing mother, and special care should be taken to avoid accidental infant ingestion if applied to the chest area.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Biogel (Ketoconazole Topical Gel) is structured around the regulatory finding of negligible systemic exposure following topical administration.


Interaction Scope

  • Specific Interacting Medicines: None explicitly listed as interacting with the topical gel formulation in regulatory documents.
  • Mechanistic Basis of Interactions: The risk of Cytochrome P450 (CYP) enzyme inhibition, such as of CYP3A4, is documented as remote due to the low quantity of active ingredient absorbed into the bloodstream. Formal drug interaction studies with the topical gel have not been performed, and plasma concentrations are typically not detectable.
  • Timing and Restrictions: No mandatory timing rules or dose-separation requirements are provided for co-administration with systemic medicinal products.
  • Population Notes: No specific cautions regarding interaction severity are documented for populations with hepatic or renal impairment.

Interaction Classifications (High-Level)

  • Interaction Severity Classification: Clinically relevant systemic drug interactions are officially classified as remote or unlikely by regulatory agencies.
  • Interaction-Context Constraints: The absence of relevant systemic interactions is constrained by the minimal systemic absorption of the active ingredient from the topical application site.

Connection to the overall interaction profile: The regulatory documents establish that the official interaction structure is defined by the negligible systemic exposure. This pharmacokinetic reality means the product is not formally associated with the extensive list of systemic interaction risks that characterize the oral formulation. The label therefore does not specify contraindicated co-administrations or restrictions for use with other systemic medications.

Mechanism of Action

Inhibition of Ergosterol Biosynthesis

The primary mechanism of Biogel (Ketoconazole) involves targeted inhibition within fungal cell metabolism, leading to membrane disruption and eicosanoid pathway modulation. The mechanism commences with the competitive inhibition of the fungal enzyme Cytochrome P450 14alpha-demethylase (CYP51). This enzyme is required for the metabolic process that converts lanosterol into ergosterol, the sterol essential for the structural and functional integrity of the fungal cell membrane. This blockage prevents ergosterol synthesis and causes toxic, methylated sterol precursors to accumulate. The resulting structural defects lead to membrane functional impairment and the arrest of cellular growth.


Fungistatic Action and Eicosanoid Pathway Modulation

The consequence of the structural defects within the fungal cell membrane is fungistasis, which is the physiological halting of fungal growth and replication. The compound also engages secondary mechanisms that involve the modulation of eicosanoid synthesis, including mediators such as prostaglandins and leukotrienes. This dual action involves both metabolic inhibition of the pathogen and modulation of host eicosanoid mediators, defining the compound's overall pharmacological profile.

Dosage and Administration Information

How to use Biogel — Administration and Use Guidelines

The name Biogel (or variations like Biogel PI, Biogel Skinsense, etc.) is primarily associated with a line of sterile surgical gloves and other non-drug medical devices. These products are medical devices intended to provide a protective barrier in surgical and healthcare settings, and therefore do not have a drug-style "Dosage and Administration" section with rules for systemic dosing, frequency, or preparation.


Device Use Scope

The primary use of Biogel surgical gloves is as a disposable device intended to be worn on the hands of healthcare personnel, typically in a surgical setting. This use is procedural and context-dependent, providing a barrier against potentially infectious material and other contaminants.

Administration Scope Use Requirement (Device)
Route of administration Not applicable; device is worn topically (on hands) as a barrier.
Dosing schedule Not applicable; the device is single-use and disposable.
Age-group rules Not specified; procedural use determined by the surgical context.

Procedural Structure

Because the product is a sterile barrier device, the procedural steps are related to aseptic technique, not pharmaceutical administration. The use is defined by its indication as a physical barrier in environments requiring sterility, such as an operating room or other invasive procedure areas. This use context dictates that the device must be worn appropriately, as defined by standard surgical protocol, and discarded after use.

Connection to the overall use protocol: Biogel is categorized as a non-drug, non-biologic device for use as a sterile physical barrier. The product's intended function and associated use protocol are therefore defined by standard surgical and infection control practices, rather than a traditional drug administration schedule.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Biogel


Evidence for Use in Seborrheic Dermatitis and Dandruff

The research underpinning Biogel's approved indication for seborrheic dermatitis, which includes what is commonly known as dandruff, is primarily based on short-term, randomized controlled trials (RCTs). These studies tracked the measurement of specific symptoms such as pruritus (itching) and scaling (flaking) severity scores, and assessed the overall clinical status after a defined treatment period. Studies reported measurements of how symptoms evolved in the observed populations over these short intervals, reflecting how patients reported their experience during the study period. Follow-up durations were typically limited to about four weeks after treatment stopped, meaning the research has not fully characterized long-term patterns or recurrence rates for this condition.


Evidence for Use in Tinea Infections (Ringworm, Jock Itch, Athlete's Foot)

Biogel was evaluated in studies exploring its use in managing superficial fungal conditions, including Tinea Corporis (ringworm), Tinea Cruris (jock itch), and Tinea Pedis (athlete's foot). Research examined outcomes related to physical discomfort and clinical appearance, aiming to confirm whether the fungal organism was no longer detectable (mycological cure). Research indicates that the available data specifically focused on the topical gel formulation are less abundant across these three Tinea indications than data focused on the cream formulation.


Gaps and Uncertainties in the Research Landscape

Evidence highlights that studies have mostly monitored responses over defined, relatively short time intervals. The existing research provides limited data on whether an initial measured change is maintained over many months, and the long-term effects are not fully established. Furthermore, comparative evidence directly evaluating the gel formulation against other topical antifungal agents is scarce. Data for certain groups, such as children under 12 years of age, also remain insufficient, meaning the results apply only to the populations studied in the research.

Frequently Asked Questions (FAQ)

Common questions about Biogel (FAQ)


Q: Can Biogel cause a skin rash or irritation?

Yes, official product information indicates that the most commonly reported side effects occur at the application site. These adverse reactions can include a burning sensation, redness (erythema), and itching (pruritus). Less common reactions, such as irritation or contact dermatitis, have also been documented.


Q: Can I apply a heating pad over the area where I put Biogel?

The product is officially classified as flammable. Based on this safety warning, patients are cautioned to avoid using heat, open flame, or smoking near the area during and immediately after applying the gel to the skin.


Q: Can I apply makeup or lotion over Biogel?

Patient information for the gel formulation suggests that other topical products, such as cosmetics or sunscreens, may typically be applied to the treated area. Some product information suggests that if other topical products are applied, a waiting period (often 20 minutes) may be necessary after applying the gel.


Q: Why do doctors recommend Biogel over oral medication sometimes?

The topical gel formulation may be used instead of the oral form in certain situations because its systemic absorption into the bloodstream is minimal or non-detectable. This low absorption helps avoid the risk of serious systemic toxicities, such as liver complications, which are associated with the oral version of the active ingredient.


Q: Why do some users feel a burning sensation with Biogel?

A burning sensation is a known, commonly reported adverse reaction that occurs directly at the application site. Official documentation lists this as a side effect, but the exact physiological mechanism for the burning sensation is not specified in the regulatory information.


Q: What are the main ingredients besides the active drug in Biogel?

The product contains the active ingredient, ketoconazole 2%, along with several inactive ingredients, known as excipients. These can include propylene glycol, purified water, and various alcohols and other components that form the gel base and facilitate application.


Q: How should I store Biogel?

Official labeling requires Biogel to be stored at Controlled Room Temperature, typically 25 C (77 F), with limited excursions allowed. It must be protected from freezing and excessive heat to maintain the product's quality.


Q: Are there any foods or drinks that interact with Biogel?

Since very little of the active ingredient is absorbed into the bloodstream, food and drink interactions are considered unlikely with the topical gel. Interactions are primarily a concern with the systemic (oral) formulation of the medication.


Q: Does Biogel interact with common vitamins or supplements?

Systemic interactions with vitamins or supplements are considered remote due to the minimal absorption of the gel. However, product labels suggest patients inform their healthcare provider about all prescription and non-prescription medicines, vitamins, and supplements being used.


Q: Can Biogel be used on broken or irritated skin?

The topical gel is intended for application on intact skin. Official information generally indicates that the product should not be applied to skin areas with cuts, scrapes, or burns. If accidental contact occurs, rinsing the area with water is usually recommended.


Q: What happens if I use too much Biogel?

An overdose of the topical gel is not expected to be hazardous because very little of the active ingredient is absorbed systemically. However, applying more than prescribed may increase the risk of developing localized skin reactions like burning, redness, or swelling.


Q: Do you need to massage Biogel into the skin completely?

Regulatory documents indicate the product should be spread evenly over the affected area, usually by gently rubbing it in. For detailed application steps, patients should refer to the official prescription instructions provided with the product.


Q: Can I use Biogel while I am pregnant or breastfeeding?

Use during pregnancy is categorized as Category C. The decision to use this product during pregnancy requires an assessment of potential benefits against potential risks. Caution is also advised during breastfeeding, especially to prevent accidental infant exposure.


Q: Can older adults use Biogel without issues?

In clinical trials, no overall differences in safety or effectiveness were observed between older adults and younger adults. Nonetheless, regulatory documents note that greater sensitivity in some older individuals cannot be entirely ruled out.


Q: Is it normal to feel a slight stinging when I first apply Biogel?

Yes, stinging at the application site has been reported as an adverse effect. This localized reaction is consistent with the product's function as a topical agent and is documented in official safety information.


Q: Can I apply Biogel more than three times a day?

Regulatory labeling indicates the product is typically prescribed for once-daily use for a specific duration. Applying the gel more often than the prescribed frequency may increase the risk of localized skin reactions.


Q: What should I do if I accidentally swallow Biogel?

The topical gel is not intended for ingestion. If the medication is accidentally swallowed, official guidance suggests contacting a Poison Help line or seeking emergency medical attention.


Q: Is Biogel available to buy without a prescription?

The specific topical gel formulation of Ketoconazole 2% is marketed as a prescription-only (Rx) medication. It is not generally available for over-the-counter purchase.


Q: Are there any long-term studies on the safety of using Biogel?

Regulatory information includes non-clinical studies, such as two-year dermal studies in animals, which demonstrated no evidence of cancer-causing potential. However, comprehensive long-term human efficacy and safety data beyond the initial clinical trials are generally not fully detailed in the product label.


How should Biogel be stored and disposed of?

How to Store and Dispose of Biogel (Ketoconazole) Topical Gel

The storage and disposal instructions for Ketoconazole Topical Gel are defined by regulatory labeling to maintain the product's integrity and ensure safe handling.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 25 C (77 F), with permitted excursions between 15 C to 30 C (59 F to 86 F).
Prohibitions Protect from freezing and excessive heat. Do not store in a bathroom.
Container Keep the product in its original container and ensure it is tightly closed when not in use.
Handling Avoid using or storing near fire, flame, or smoking as the contents are flammable.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Biogel must not be discarded by flushing down a toilet or pouring down a drain.

Regulated disposal requires consulting with a pharmacist to utilize approved medication take-back programs or local procedures for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biogel found in:

A-Z Index: